Pfizer has informed that a teleconference call has been scheduled with the analysts on May 06, 2016, at 4.30 p.m. to discuss the Company’s financial performance for the quarter and the financial year ended March 31, 2016.
The above information is a part of company’s filings submitted to BSE.